Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
H3N2 infection - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Personalized Medicine Market Report by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2024-2032
... & Academic Institutes, and Others), Region and Company Analysis 2024-2032 The global personalized medicine market was worth US$ 511.09 billion in 2023 and is expected to grow at a CAGR of 7.02% from 2024 to ... Read More
-
Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024
... development scenario and growth prospects across the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) market. A detailed picture of the Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) pipeline landscape is provided, which includes the disease overview and ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Global Pneumonia Vaccine Market Growth 2024-2030
... Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pneumonia Vaccine market. Pneumonia Vaccine ... Read More
-
2024 Global Forecast for Microneedle Flu Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Measles, Mumps And Rubella (Mmr) Vaccines Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Infectious Disease Therapeutics Market Assessment, By Mode of Treatment [Vaccines, Drugs], By Infection Type [Viral Infection, Bacterial Infection, Fungal Infection, Parasitic Infection, Others], By Route of Administration [Oral, Parenteral, Others], By Diagnostic Technique [Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F
... Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F Global infectious disease therapeutics ... Read More
-
2024 Israel Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
2024 Panama Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
2024 Myanmar Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Biopharmaceuticals Contract Manufacturing market size is poised to register 5.82% growth from 2024 to 2030, presenting significant ... Read More
-
Viral Vector Production Market Size, Trends, Analysis, and Outlook By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology), By Viral Vector (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Production market size is poised to register 17.68% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Recombinant Proteinrapeutics CDMO Market Size, Trends, Analysis, and Outlook By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source (Mammalian Systems, Microbial Systems, Others), By Indication (Oncology, Infectious Diseases, Immunological Disorders, Metabolic Disorders, Haematological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Recombinant Proteinrapeutics CDMO market size is poised to register 12.58% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Point of Care Infectious Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Global Hospital Acquired Pneumonia Drugs Market Growth 2024-2030
... in downstream market, the Hospital Acquired Pneumonia Drugs is forecast to a readjusted size of US$ 3059.9 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
mRNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global mRNA Therapeutics market size is poised to register 2.16% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mRNA ... Read More
-
mRNA Therapeutics Contract Development and Manufacturing Market Size, Trends, Analysis, and Outlook By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global mRNA Therapeutics Contract Development and Manufacturing market size is poised to register 11.37% growth from 2024 to ... Read More
-
The 2025-2030 World Outlook for Hospital Infection Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
